Showing results (191-200 of 6,999) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|August 31, 2023
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutationsTakashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2023
Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancerLiang Zeng, Yuling Zhou, Qinqin Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2023
The search for therapeutic targets in lung cancer: Preclinical and human studies of carcinoembryonic antigen-related cell adhesion molecule 5 expression and its associated molecular landscapeAnne-Marie Lefebvre, Julien Adam, Céline Nicolazzi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 4, 2023
Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancerHsiu-Ying Ku, Shih-Min Lin, Chih-Liang Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2023
Association of telomere length with risk of lung cancer: A large prospective cohort study from the UK BiobankDuoduo Han, Yiqun Zhu, Abira A Choudhry, et al.
Lung Cancer (Amsterdam, Netherlands)|August 5, 2023
Alectinib relieves ischemic strokes caused by left atrial metastasis in a NSCLC patient with a novel SLC34A2-ALK (exon 1: exon 15) fusionNa Zhou, Mingying Wu, Mingming Yuan, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2023
Efficacy and safety of re-challenging 160 mg furmonertinib for advanced NSCLC after resistance to third-generation EGFR-TKIs targeted agents: A real-world studyRongbin Qi, Xinyu Fu, Yingying Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2023
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)Agathe Dehem, Julien Mazieres, Ali Chour, et al.
Lung Cancer (Amsterdam, Netherlands)|October 6, 2023
Long-term outcomes of lung cancer screening in males and femalesMargherita Ruggirello, Camilla Valsecchi, Roberta Eufrasia Ledda, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2023
Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysisRafael Parra-Medina, Juan Pablo Castañeda-González, Luisa Montoya, et al.
Pageof 700